摘要
目的评价儿脾醒颗粒治疗“脾失健运证”小儿厌食症的临床有效性和安全性。方法纳入吉林市儿童医院2017年I月-2020年12月收治的200例患儿为研究对象,随机分为对照组100例,观察组100例。对照组给予参苓白术片,观察组给予儿脾醒颗粒,均治疗21d。比较两组治疗后临床疗效、进食时间、体质量、中医单项症状疗效评分等,观察不良反应发生率。结果两组经过治疗后,观察组总有效率90.00%高于对照组的80.00%,但两组比较无统计学差异(P>0.05).两组在治疗后中医单项症状面色少华、嗳气,呃逆、恶心的总有效率比较,无统计学差异(P>0.05)。而在食欲不振,食量减少,大便不调方面,观察组的总有效率显著优于对照组(P<0.05).与治疗前相比,两组治疗后均能缩短患儿进食时间,增加体质量(P<0.05)。且两组治疗后体质量、进食时间比较,无统计学差异(P>0.05)。两组治疗过程中均未发生严重不良反应事件,两组不良反应发生率比较,无统计学差异(P>0.05)。结论儿脾醒颗粒在治疗“脾失健运证”小儿厌食症方面能明显改善患儿食欲不振、食量减少。体质量、进食时间等问题,临床疗效确切,安全性高,值得临床上推广。
0bjective To evaluale the Erpixing Kell was treated pediatrir anorexia for the elinical ffectiveness and safety.Methods We included the 200 cases admited to our hospial from January 2017 to December 2020.They were grouped by random numbers and randomly divided into 100 control groups and 100 in the observation group.The control group was given Shenling Baizhu pian,and the observation group Erpixing Kell,and treating for 2Ild.Comparing clinical efrary alfer tratment,feding time,body quality,efirary score of TCM individual symptoms between the Iwo groups.and observe the incidence of adverse reacions.Results Afer treatment,.the observed group was 90.00%higher than 80.00%in the control group.However.there wer no slatistical difrerences between the Iwo groups(P>0.05).There was no statistically significant difference in the overall efficiency of low complexion.beleching and nausea afler treatment(P>0.05).The loss,of appelitr.reduced food volume and iregular stool were signifrantly better than the control group (P<0.05).Compared with pre-treatment.both children could shorten their eating time and increase their body quality afer tratment(P<0.05).Conclus ion Erpixing Kell could ignifiranly improve children with loss of appeite,reduced food volume,body quality,fating time and the preeise rlinical ffet,high safely.It is worth being clinically recommended as the lreatment of pediatric anorexia.
作者
刘晓梅
王晓波
Liu Xiaomei;Wang Xiaobo(Liaoyuan maternal and infant hospital,JiLin Liaoyuan,136299;Songyuan Central Hospital,JiLin Songyuan,138001)
出处
《首都食品与医药》
2022年第2期122-125,共4页
Capital Food Medicine
关键词
儿脾醒颗粒
厌食症
脾失健运证
临床疗效
Erpixing Kell
pediatric anorexia
splenic health transport certificate
clinical efficacy
